5 | Messenger RNA (mRNA)IBA
01/2022
-
04/2013 |
5 | Epidermal Growth Factor (EGF)IBA
11/2021
-
11/2003 |
5 | Proteins (Proteins, Gene)FDA Link
01/2019
-
10/2003 |
5 | Contrast MediaIBA
07/2007
-
11/2003 |
4 | ErbB Receptors (EGF Receptor)IBA
01/2023
-
11/2003 |
4 | GoldIBA
01/2020
-
11/2016 |
4 | Cetuximab (Erbitux)FDA Link
05/2018
-
11/2003 |
4 | paclitaxel poliglumex (XYOTAX)IBA
06/2011
-
01/2004 |
3 | CollagenIBA
11/2021
-
01/2018 |
3 | TOR Serine-Threonine KinasesIBA
08/2014
-
04/2013 |
3 | Peptides (Polypeptides)IBA
01/2012
-
04/2009 |
3 | Annexin A5IBA
06/2011
-
10/2003 |
2 | Monoclonal AntibodiesIBA
01/2023
-
11/2003 |
2 | Heparin (Liquaemin)FDA LinkGeneric
11/2021
-
01/2018 |
2 | Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
11/2021
-
01/2018 |
2 | LigandsIBA
04/2020
-
05/2014 |
2 | Immune Checkpoint InhibitorsIBA
01/2020
-
01/2019 |
2 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020
-
11/2016 |
2 | cupric sulfide (CuS)IBA
08/2019
-
07/2015 |
2 | Sirolimus (Rapamycin)FDA Link
09/2013
-
04/2013 |
2 | Pentetic Acid (DTPA)FDA LinkGeneric
08/2011
-
07/2007 |
1 | Tumor Biomarkers (Tumor Markers)IBA
01/2024 |
1 | AllergensIBA
12/2023 |
1 | ChemokinesIBA
12/2023 |
1 | Interleukin-17 (Interleukin 17)IBA
12/2023 |
1 | SirtuinsIBA
12/2023 |
1 | GlutaminaseIBA
01/2023 |
1 | Glutamine (L-Glutamine)FDA Link
01/2023 |
1 | 4-(3-fluoropropyl)glutamic acidIBA
01/2023 |
1 | RNA (Ribonucleic Acid)IBA
01/2023 |
1 | ProteomeIBA
01/2023 |
1 | 3-hydroxyphenyltrimethylammoniumIBA
01/2022 |
1 | Biomarkers (Surrogate Marker)IBA
01/2022 |
1 | Interleukin-8 (Interleukin 8)IBA
11/2021 |
1 | Circular RNAIBA
08/2021 |
1 | calcipotriene (calcipotriol)FDA LinkGeneric
05/2021 |
1 | Paclitaxel (Taxol)FDA LinkGeneric
05/2021 |
1 | Doxycycline (Periostat)FDA LinkGeneric
04/2020 |
1 | 2- (4- isothiocyanatobenzyl)- 1,4,7- triazacyclononane- 1,4,7- triacetic acidIBA
04/2020 |
1 | 2- (4- isothiocyanatobenzyl)- 1,4,7,10- tetraazacyclododecane tetraacetic acidIBA
04/2020 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
04/2020 |
1 | AntibodiesIBA
04/2020 |
1 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
04/2020 |
1 | Chelating AgentsIBA
04/2020 |
1 | CopperIBA
01/2020 |
1 | Toll-Like Receptor 9IBA
01/2020 |
1 | Sulfides (Thioethers)IBA
01/2020 |
1 | norisoboldineIBA
01/2019 |
1 | AlkaloidsIBA
01/2019 |
1 | ResveratrolIBA
01/2019 |
1 | Particulate MatterIBA
01/2019 |
1 | Sirtuin 1IBA
01/2019 |
1 | Programmed Cell Death 1 ReceptorIBA
01/2019 |
1 | isoquinolineIBA
01/2019 |
1 | Aluminum Oxide (Sapphire)IBA
05/2018 |
1 | Growth Factor ReceptorsIBA
05/2018 |
1 | VimentinIBA
01/2018 |
1 | Annexin A1IBA
01/2018 |
1 | Cadherins (E-Cadherin)IBA
01/2018 |
1 | Folic Acid (Vitamin M)FDA LinkGeneric
01/2018 |
1 | AntigensIBA
01/2017 |
1 | tanespimycin (17AAG)IBA
01/2017 |
1 | Axl Receptor Tyrosine KinaseIBA
01/2017 |
1 | Glutamic Acid (Glutamate)FDA Link
01/2017 |
1 | fosbretabulin (combretastatin A4)IBA
11/2016 |
1 | Ethiodized Oil (Ethiodol)FDA Link
11/2016 |
1 | Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
11/2016 |
1 | Phosphates (Orthophosphate)IBA
11/2016 |